BioXcel Therapeutics, Inc. (BTAI): Price and Financial Metrics

BioXcel Therapeutics, Inc. (BTAI): $2.55

0.43 (-14.43%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

BTAI Price/Volume Stats

Current price $2.55 52-week high $61.12
Prev. close $2.98 52-week low $2.51
Day low $2.51 Volume 230,200
Day high $2.93 Avg. volume 214,195
50-day MA $5.82 Dividend yield N/A
200-day MA $14.34 Market Cap 7.91M

BTAI Stock Price Chart Interactive Chart >


BioXcel Therapeutics, Inc. (BTAI) Company Bio


BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on novel artificial intelligence-based drug development in the fields of neuroscience and immuno-oncology in the United States. The company is involved in developing BXCL501, a sublingual thin film formulation of dexmedetomidine designed for acute treatment of agitation resulting from neurological and psychiatric disorders; and BXCL701, an immuno-oncology agent designed for the treatment of prostate and pancreatic cancers. It is also developing BXCL502, a novel approach to the treatment of symptoms resulting from neurological disorders; and BXCL702, an immuno-oncology agent for hematological malignancies. The company was founded in 2017 and is based in Branford, Connecticut. BioXcel Therapeutics, Inc. is a subsidiary of BioXcel Corporation.


BTAI Latest News Stream


Event/Time News Detail
Loading, please wait...

BTAI Latest Social Stream


Loading social stream, please wait...

View Full BTAI Social Stream

BTAI Price Returns

1-mo -58.47%
3-mo -69.37%
6-mo -76.33%
1-year -93.52%
3-year -99.10%
5-year -99.57%
YTD -57.37%
2024 -87.33%
2023 -86.27%
2022 5.66%
2021 -56.00%
2020 216.22%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!